Balyasny Asset Management
AGN

Balyasny Asset Management’s Allergan plc AGN Stock Holding History

Balyasny Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-521,560
Closed -$92.4M – 1637
2020
Q1 		$92.4M Sell
521,560
-1,908
-0.4% -$359K 1.1% 3
2019
Q4 		$100M Buy
523,468
+188,879
+56% +$34.1M 0.6% 24
2019
Q3 		$56.3M Buy
334,589
+254,222
+316% +$41.4M 0.39% 49
2019
Q2 		$13.5M Sell
80,367
-53,267
-40% -$7.38M 0.09% 326
2019
Q1 		$19.6M Sell
133,634
-186,736
-58% -$27.1M 0.13% 227
2018
Q4 		$42.8M Buy
320,370
+304,922
+1,974% +$50M 0.31% 76
2018
Q3 		$2.94M Sell
15,448
-59,605
-79% -$10.9M 0.01% 872
2018
Q2 		$12.5M Sell
75,053
-329,540
-81% -$52.9M 0.06% 423
2018
Q1 		$68.1M Buy
404,593
+303,672
+301% +$50.9M 0.28% 75
2017
Q4 		$16.5M Buy
100,921
+26,491
+36% +$4.75M 0.05% 474
2017
Q3 		$15.3M Sell
74,430
-208,685
-74% -$48.5M 0.06% 390
2017
Q2 		$68.8M Buy
283,115
+249,757
+749% +$58.7M 0.28% 81
2017
Q1 		$7.97M Sell
33,358
-302,822
-90% -$70.5M 0.04% 574
2016
Q4 		$70.6M Buy
+336,180
New +$69.6M 0.38% 47
2016
Q2 		– Sell
-8,750
Closed -$2.02M – 1562
2016
Q1 		$2.35M Sell
8,750
-196,260
-96% -$56.2M 0.01% 668
2015
Q4 		$64.1M Buy
205,010
+21,970
+12% +$6.54M 0.44% 47
2015
Q3 		$49.8M Sell
183,040
-204,614
-53% -$62.9M 0.37% 70
2015
Q2 		$118M Buy
387,654
+290,750
+300% +$86.7M 0.72% 19
2015
Q1 		$28.8M Sell
96,904
-75,308
-44% -$21.5M 0.23% 132
2014
Q4 		$44.3M Sell
172,212
-62,966
-27% -$15.7M 0.41% 51
2014
Q3 		$56.7M Buy
235,178
+115,221
+96% +$25.8M 0.44% 43
2014
Q2 		$26.8M Sell
119,957
-36,057
-23% -$7.47M 0.3% 59
2014
Q1 		$32.1M Buy
156,014
+4,782
+3% +$947K 0.36% 62
2013
Q4 		$25.4M Buy
+151,232
New +$23.6M 0.33% 78
2013
Q3 		– Sell
-280,772
Closed -$35.4M – 759
2013
Q2 		$35.4M Buy
+280,772
New +$31.8M 0.6% 30

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Balyasny Asset Management's AGN Position: Q2 2020 in Review

Balyasny Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 521,560 shares — an estimated $92.4M sold.

Balyasny Asset Management first reported a position in AGN in Q2 2013 and held it in 25 quarters. The position peaked at $118M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Balyasny Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Balyasny Asset Management sold 521,560 Allergan plc shares in Q2 2020, an estimated $92.4M.
  • Balyasny Asset Management first reported a position in Allergan plc in Q2 2013 and held it in 25 quarters.
  • Balyasny Asset Management's Allergan plc position peaked at $118M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Balyasny Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.